BALYASNY ASSET MANAGEMENT L.P. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q1 2023$2,580,443
-84.8%
107,653
-89.3%
0.01%
-87.2%
Q4 2022$17,031,826
+238.6%
1,004,235
+195.9%
0.05%
+213.3%
Q3 2022$5,030,000
+2858.8%
339,383
+3039.8%
0.02%
+1400.0%
Q2 2022$170,000
-85.1%
10,809
-59.4%
0.00%
-87.5%
Q3 2020$1,142,000
-80.2%
26,628
-78.4%
0.01%
-84.0%
Q2 2020$5,766,000123,3780.05%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2022
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders